Pharmaceutical Regulatory Consulting Services
Pharmaceutical regulatory consulting helps companies make better choices during product development. It can also help prevent costly regulatory mistakes. XFDA Pharma Advisors supports pharmaceutical teams at each stage of the regulatory process. We provide clear guidance and simple documentation. Our team also gives hands-on support when needed.
We assist with regulatory submissions, agency reviews, inspections, and product lifecycle needs. We work with new companies, established manufacturers, and businesses entering regulated markets. Every project starts with a clear review of your product and available data. We also look at your business goals and current regulatory status. This helps us provide support that fits your needs.
Why Regulatory Support Matters More Than Ever
Every stage of drug development runs on a tight timeline, while regulatory requirements keep changing. A change in CMC data, a new manufacturing site, or a new target market can bring new regulatory needs under FDA, EMA, or ICH guidelines. Internal teams may have the right skills but not enough time. This can be a major issue during a submission or when an agency sends a new request.
That is where pharmaceutical regulatory consulting can help. You get support from experts who understand FDA reviews, eCTD submissions, and Form 483 responses. You get this support without the cost of hiring a full-time team. XFDA Pharma Advisors helps turn complex documents and changing rules into a clear action plan. We work with your quality, clinical, manufacturing, and leadership teams. We find gaps early and track each task. This helps your team stay on track and avoid missed steps.
Our Services
FDA & Pharmaceutical Compliance Consulting Services
XFDA Pharma Advisors provides specialized FDA consulting and pharmaceutical compliance services to pharmaceutical, biopharmaceutical, API, OTC, sterile manufacturing, and CMO/CDMO organizations in the United States and globally.
Our team of former FDA professionals and senior pharmaceutical industry experts provides hands-on support for FDA inspection readiness, CGMP compliance, regulatory remediation, laboratory operations, data integrity, quality systems, and complex manufacturing compliance challenges.
Whether you are preparing for an FDA inspection, responding to regulatory observations, addressing significant compliance deficiencies, or strengthening your Pharmaceutical Quality System, we provide practical, risk-based solutions designed to achieve and maintain a state of control.
FDA Inspection Readiness & Mock FDA Inspections
Prepare your facility, systems, documentation, and personnel before FDA arrives.
XFDA Pharma Advisors conducts mock FDA inspections and FDA inspection readiness assessments for Pre-Approval Inspections (PAIs), surveillance inspections, and other FDA inspections.
Our support includes FDA six-system assessments, facility and laboratory walkthroughs, document readiness, front-room and back-room preparation, SME interview coaching, inspection simulations, and identification of potential CGMP deficiencies.
FDA 483 Response Consulting
Received a Form FDA 483? XFDA Pharma Advisors helps organizations evaluate FDA observations, determine root causes and systemic impact, develop appropriate CAPAs, and prepare comprehensive responses supported by credible remediation plans and
evidence.
Our support includes 483 response development, root cause analysis, retrospective review strategies, CAPA development, remediation planning, effectiveness verification, and FDA follow-up inspection readiness.
FDA Warning Letter Remediation
XFDA Pharma Advisors provides comprehensive FDA Warning Letter response and remediation support for organizations facing significant CGMP and regulatory compliance issues.
Our former FDA and industry experts assist with comprehensive gap assessments, root cause investigations, systemic impact evaluations, CAPA development, retrospective reviews, data integrity remediation, quality-system remediation, FDA meeting preparation, and reinspection readiness.
FDA Pre-Approval Inspection (PAI) Readiness
Our PAI readiness consultants help pharmaceutical manufacturers prepare their facilities, systems, data, documentation, and personnel for FDA Pre-Approval Inspections.
Assessments may include CMC-to-site verification, process validation, analytical method readiness, laboratory controls, stability programs, batch records, data integrity, equipment qualification, quality systems, and employee interview preparation.
Pharmaceutical Data Integrity Consulting
XFDA Pharma Advisors performs comprehensive pharmaceutical data integrity assessments and remediation across laboratory, manufacturing, quality, and computerized systems.
Our assessments cover ALCOA+ principles, audit trails, user access, electronic records, chromatography systems, standalone equipment, spreadsheets, backup and restoration, data governance, retrospective reviews, and data integrity investigations.
Pharmaceutical Laboratory Compliance
Our pharmaceutical laboratory compliance consultants assess QC chemistry and microbiology operations from both scientific and FDA CGMP perspectives.
Areas of focus include OOS/OOT investigations, laboratory incidents, chromatography systems, audit trails, analytical method validation and verification, system suitability, stability programs, reference standards, equipment qualification, analyst training, electronic records, and laboratory data integrity.
CGMP & Pharmaceutical Quality Systems
XFDA Pharma Advisors helps organizations assess, strengthen, and remediate their Pharmaceutical Quality Systems and CGMP compliance programs.
Our expertise includes Quality Unit oversight, deviations, investigations, CAPA, change control, complaints, APR/PQR, quality risk management, training, document control, batch record review, internal audits, quality metrics, and management oversight.
Sterile Manufacturing & Aseptic Processing
Our sterile GMP consultants support sterile drug manufacturers with aseptic processing, contamination control, environmental monitoring, media fills, personnel qualification, gowning, cleaning and disinfection, cleanroom controls, microbiology systems, utilities, pharmaceutical water systems, and sterility assurance.
We also support FDA inspection readiness and EU GMP Annex 1 / Contamination Control Strategy (CCS) assessments.
API Manufacturing & ICH Q7 Compliance
XFDA Pharma Advisors provides API GMP consulting, ICH Q7 assessments, and FDA inspection readiness support for active pharmaceutical ingredient manufacturers.
Our assessments cover starting materials, raw materials, manufacturing controls, laboratory operations, analytical methods, impurities, process validation, cleaning, crosscontamination, investigations, CAPA, data integrity, supplier qualification, and quality oversight.
CMO/CDMO Audits & Supplier Qualification
Effective outsourcing requires effective quality oversight.
XFDA Pharma Advisors conducts CMO/CDMO audits, pharmaceutical supplier qualification audits, and independent GMP assessments to help organizations evaluate and oversee contract manufacturers, laboratories, and critical suppliers.
Our support includes qualification and requalification audits, quality agreement reviews, investigation and CAPA assessments, laboratory oversight, quality-system assessments, and regulatory inspection readiness.
CMC & Regulatory Compliance Support
Our experts provide compliance-focused CMC consulting and regulatory documentation support, including Module 3 reviews, manufacturing process documentation, specifications, analytical procedures, method validation and verification, stability, process validation, and raw material controls.
A key focus is identifying potential gaps between regulatory commitments and actual manufacturing, laboratory, and quality-system practices before they become regulatory issues.
Pharmaceutical Validation & Qualification
XFDA Pharma Advisors provides independent pharmaceutical validation and qualification consulting covering process validation, cleaning validation, equipment qualification, IQ/OQ/PQ, computerized system validation, laboratory equipment, facilities, utilities, and Continued Process Verification.
We evaluate whether programs are scientifically justified, appropriately documented, and capable of demonstrating a continued state of control.
Independent Remediation & Quality Oversight
For organizations undergoing significant regulatory or CGMP remediation, XFDA Pharma Advisors provides independent remediation and quality oversight from initial assessment through effectiveness verification.
Support may include CAPA oversight, retrospective reviews, investigation assessments, batch and laboratory record reviews, quality-system remediation, periodic effectiveness assessments, management reporting, and FDA reinspection readiness.
FDA Inspection Training & Coaching
Prepare your people—not just your documents.
XFDA Pharma Advisors provides customized FDA inspection training and coaching for executives, Quality Unit personnel, manufacturing teams, laboratory personnel, SMEs, and inspection support teams.
Training includes FDA investigator interactions, SME interview preparation, inspection behavior, front-room and back-room operations, document request management, data integrity, OOS investigations, CAPA, laboratory compliance, and Good Documentation Practices.
Why Choose XFDA Pharma Advisors?
Former FDA Experience. Senior Industry Expertise. Hands-On Support.
XFDA Pharma Advisors brings together former FDA professionals and senior pharmaceutical industry experts with extensive experience in FDA inspections, pharmaceutical manufacturing, laboratory operations, quality systems, data integrity, and complex regulatory remediation.
We don’t simply identify compliance gaps. We help organizations understand why the gap exists, its potential regulatory significance, what needs to be corrected, and how to demonstrate that corrective actions are sustainable and effective.
From FDA inspection readiness and mock FDA inspections to 483 responses, Warning Letter remediation, PAI readiness, data integrity, laboratory compliance, and independent remediation oversight, XFDA Pharma Advisors provides practical support throughout the compliance lifecycle.
Need FDA Compliance Support?
Whether you are preparing for an upcoming FDA inspection or PAI, responding to a Form FDA 483 or Warning Letter, addressing data integrity concerns, or managing a complex CGMP remediation, our team is ready to help.
Talk With a Former FDA Consultant
Schedule a confidential consultation with XFDA Pharma Advisors to discuss your FDA compliance and inspection-readiness needs.
Regulatory Affairs Consulting Across Your Product Lifecycle
Each product stage has its own needs. Regulatory affairs consulting should match the product stage, risk, and goals.
Early-stage companies may need help with the right path. They may also need help to find data gaps. Later, teams may need help with submissions and file checks. Established companies may need help with changes, new registrations, or ongoing compliance.
During early work, we help clients find the right regulatory path. During clinical work, we help with key files and plans for talks with regulators. During filing, we help teams get ready for review and submission.
After approval, we help with changes that need a review. Pharmaceutical regulatory consulting can also help when new needs arise.
Our approach is flexible. Some clients need a pharmaceutical regulatory consultant for a short project. Others need long-term help across many programs.
Our pharmaceutical regulatory consultants can work with your regulatory lead or outside experts. The goal is simple: give you the right support at each stage.
How We Work With You
A Practical, Risk-Based Approach to FDA Compliance.
Every engagement begins with understanding your specific regulatory and compliance needs. Whether you are preparing for an FDA inspection, addressing Form FDA 483 observations or a Warning Letter, strengthening your quality systems, or preparing for a PreApproval Inspection (PAI), XFDA Pharma Advisors provides a structured, risk-based approach tailored to your operation.
Step 1: Initial Consultation
We begin with an introductory consultation to understand your facility, products, regulatory status, current challenges, and objectives. This discussion allows us to identify your immediate priorities and determine the appropriate scope of support.
Step 2: Assessment & Gap Analysis
Our experts evaluate the relevant systems, procedures, records, and regulatory documentation against applicable FDA requirements and industry expectations. Depending on the engagement, this may include a comprehensive CGMP assessment, mock FDA inspection, laboratory or data integrity assessment, quality-system review, inspection-readiness assessment, or targeted review of a specific compliance concern. The objective is not simply to identify gaps, but to determine their significance and prioritize the areas requiring attention.
Step 3: Compliance Strategy & Remediation Roadmap
Based on our findings, we develop a practical roadmap that defines priorities, recommended corrective actions, responsibilities, and next steps. For remediation projects, we help your team address root causes and develop sustainable CAPAs rather than relying on short-term corrections. For inspection-readiness engagements, we focus resources on the systems and activities most likely to receive regulatory scrutiny
Step 4: Implementation & Hands-On Support
Our consultants work directly with your team to implement the agreed strategy. Support may include procedure development and revision, CAPA remediation, investigation review, data integrity improvements, quality-system enhancements, inspection preparation, frontroom and back-room coaching, CMC documentation review, and preparation of regulatory responses. Our approach is collaborative and practical, with solutions designed to work within your actual operations—not just on paper.
Step 5: Verification & Inspection Readiness
Before the engagement is completed, we evaluate whether key corrective actions and improvements have been effectively implemented. When FDA inspection readiness is the objective, this may include follow-up assessments, mock interviews, document challenges, facility walkthroughs, inspection simulations, and verification of supporting evidence.
Step 6: Ongoing Regulatory & Compliance Support
FDA compliance does not end when an audit or remediation project is completed. XFDA Pharma Advisors can continue supporting your organization through FDA inspections, regulatory responses, CAPA effectiveness verification, quality-system improvements, CMO/CDMO oversight, and evolving compliance needs.
From identifying the problem to implementing and verifying the solution, XFDA Pharma Advisors provides experienced, hands-on support throughout the FDA compliance lifecycle.
Why Work With XFDA Pharma Advisors
Pharmaceutical regulatory consulting can help teams make sound choices during key product changes. The right advisor should understand both the details and the need to act quickly. XFDA Pharma Advisors takes a practical approach to each project. We do not give generic advice. We review your product, needs, and current situation, then help your team focus on the next step.
Our advice is clear and linked to your main goal. We also document key points so your team can use them with ease. Our team works with professionals in quality, manufacturing, technical operations, and business roles. We also work well with pharmaceutical regulatory consultants who are already part of your team.
Regulatory affairs consulting works best when advisors and internal teams share information early. This helps leaders see project risks and resource needs more clearly. We believe regulatory advice should be easy to understand and use. A pharmaceutical regulatory consultant from our team can turn key rules into clear tasks. Your team can then assign owners, track progress, and make decisions with confidence. This approach helps teams act faster without adding unnecessary admin work.
Industries We Serve
Specialized FDA & CGMP Consulting Across Pharmaceutical and Life Sciences Manufacturing.
XFDA Pharma Advisors supports pharmaceutical, biopharmaceutical, and regulated product manufacturers with practical, inspection-focused compliance solutions. Our team of former FDA investigators, compliance professionals, and senior industry experts brings extensive experience in FDA inspections, CGMP compliance, quality systems, laboratory operations, data integrity, and regulatory remediation. Our experience includes:
Prescription Pharmaceuticals
Brand and generic drug manufacturers, including NDA and ANDA products.
Active Pharmaceutical Ingredients (APIs)
API and intermediate manufacturers operating under FDA CGMP and ICH Q7 expectations.
Sterile & Aseptic Products
Sterile drug products, aseptic processing operations, contamination control, and microbiological systems.
Biologics & Biopharmaceuticals
Quality systems, manufacturing controls, laboratory operations, and FDA inspection readiness.
Over-the-Counter (OTC) Drugs
OTC drug manufacturing, testing, packaging, quality systems, and FDA CGMP compliance.
Contract Manufacturers & CDMOs/CMOs
FDA inspection readiness, qualitysystem assessments, client oversight, supplier qualification, and remediation support.
Pharmaceutical Laboratories
QC chemistry and microbiology laboratories, data integrity, OOS/OOT investigations, method validation/verification, and laboratory controls.
Drug-Device Combination Products
CGMP and quality-system support for pharmaceutical operations involving combination products.
Transdermal & Drug-Delivery Products
Manufacturing, laboratory, cleaning, cross-contamination, and quality-system controls.
Cosmetics & Personal Care Products
FDA compliance and MoCRA readiness, including quality systems, manufacturing controls, and facility preparedness.
Whether preparing for an FDA Pre-Approval Inspection (PAI), surveillance inspection, responding to a Form FDA 483 or Warning Letter, addressing data-integrity concerns, or strengthening an existing Pharmaceutical Quality System, XFDA Pharma Advisors provides hands-on support based on real FDA and industry experience.
Speak With Our Regulatory Team
Your regulatory plan should help your product move forward. It should not slow your work down. XFDA Pharma Advisors offers pharmaceutical regulatory consulting based on your needs and goals. Whether you need a clear roadmap, document review, filing support, or help after approval, our team can help. We work with you to understand your product, key dates, and main needs.
Contact XFDA Pharma Advisors to discuss your next step and the support your team needs.
Frequently Asked Questions
It depends on your product and stage. Our work may include pathway planning, file and data review, filing support, eCTD support, and work after approval. We agree on the work with you before the project starts. This gives your team a clear view of the tasks, goals, and final results.
It is best to bring in a regulatory consultant early. This is useful before a key pathway choice, agency meeting, or filing date. Early support gives your team time to find and fix gaps. It also helps you avoid last-minute work when a key date is close.
Yes. We support IND, NDA, ANDA, and BLA filings. We review files against the CTD format and check that key data can be traced to the right source. We can also help your team get ready for eCTD publishing. The work depends on your filing type and the files you have.
Yes. We support FDA and EMA work. Our team can help with both central and local EU filing routes. We also help prepare for Scientific Advice meetings and CTD-based filings. Our support is based on the needs of your product and target market.
Yes. We support work after approval, such as reportable changes, supplement filings, label updates, and ongoing tracking. You can use our help for one project or on a longer basis. We can adjust the level of support to match your team's needs.